Neutrophil migration is essential for inflammatory responses to kill pathogens and cause tissue injury. To discover novel therapeutic targets that modulate neutrophil migration, we performed a neutrophil-specific microRNA overexpression screen in zebrafish, and identified eight microRNAs as potent suppressors of neutrophil migration. Among those, miR-199 decreases neutrophil chemotaxis in zebrafish and human neutrophil-like cells. Intriguingly, in terminally differentiated neutrophils, miR-199 alters the cell cycle-related pathways and directly suppresses cyclin-dependent kinase 2 (cdk2), whose known activity is restricted to cell cycle progression and cell differentiation. Inhibiting CDK2, but not DNA replication, disrupts cell polarity and chemotaxis of zebrafish neutrophils. Chemotaxis of primary human neutrophils are also reduced by CDK2 inhibition. Furthermore, miR-199 overexpression or CDK2 inhibition significantly improves the outcome of lethal systemic inflammation challenges in zebrafish. Together, our results reveal previously unknown functions of miR-199 and CDK2 in regulating neutrophil migration and provide new directions in alleviating systemic inflammation.
Introduction
Neutrophils are the first cells recruited to an immune stimulus stemming from infection or sterile injuries via a mixture of chemoattractant cues 1 . In addition to eliminating pathogens, neutrophils coordinate the overall inflammation response by causing tissue damage and modulating the activation of other immune cells. Over amplified or chronic neutrophil recruitment directly leads to autoimmune diseases including rheumatic arthritis, diabetes, neurodegenerative diseases, and cancer 2 . Dampening neutrophil recruitment is a strategy to intervene neutrophil-orchestrated chronic inflammation 3 . Despite intensive research over the past several decades, clinical studies targeting neutrophil migration have been largely unsuccessful, possibly due to the prominent redundancy of adhesion receptors and chemokines. Additional challenges lie in the balance of dampening detrimental inflammation while preserving immunity 4 . Neutrophil migration is governed by spatially and temporally complex dynamic signaling network 5 . Immune cells use both mesenchymal migration (adhesive migration on substrate) and amoeboid migration (actin protrusion driven by weak substrate interaction) to infiltrate tissue using distinct signaling molecules 6, 7 . Extensive research is required to understand the machinery regulating neutrophil recruitment, which can lead to the development of exogenous inhibitors for clinical use.
MicroRNAs (miRNAs) are short (20-22 nucleotides) conserved non-coding RNAs that are epigenetic regulators of the transcriptome. By binding primarily to the 3´UTRs of their target transcripts and recruiting the RNA-induced silencing complex, miRNAs down-regulate gene expression 8 . miRNAs are generally fine-tuners that suppress gene expression at modest levels, and also master regulators that target the expression of a network of genes 9 . Recently, miRNAs and anti-miRNAs have been used in clinical trials to treat cancer and infection 10 . In addition, they have been used as tools to screen and identify the underlying mechanisms of diseases and cell behavior 11, 12 . In immune cells, an in vivo functional screen of microRNA was performed to identify microRNAs that regulate B cell tolerance 13 . In neutrophils, the functions of the highly expressed microRNAs miR-223 14 and miR-142 15 have been well characterized. However, other miRNAs and their targets as regulators of neutrophil recruitment remain largely unknown. The absence of this knowledge might lead to missed opportunities in harnessing microRNAs and their targets in restraining neutrophilic inflammation.
The zebrafish is a suitable model organism to study neutrophil biology. They have an evolutionarily conserved innate immune system, including the phagocytes and their signaling molecules including miRNAs 15, 16 . The transparent property of zebrafish embryos enables noninvasive imaging of neutrophil behavior under physiological conditions 17, 18 . Additionally, high fecundity and established genetic tools make zebrafish an ideal platform for genetic screens and drug discovery 19 .
We have previously established a system to express individual miRNAs in zebrafish neutrophils to assess their function in vivo 20 . Here we performed a miRNA overexpression screen and identified miR-199 as a novel regulator of neutrophil chemotaxis. Through miR-199 target analysis, we identified the canonical cell cycle related gene cdk2 as a new regulator of neutrophil migration. Overexpression of miR-199 or inhibition of cdk2 in neutrophils improved survival upon infection and sterile inflammatory challenges. Our results were further validated in human neutrophil-like cells and primary human neutrophils, supporting the evolutionary conservation of miR-199 and Cdk2 in vertebrae neutrophil biology. Our discovery expands our current understanding of neutrophil migration and suggests a novel strategy to manage neutrophilic inflammation.
Results

Identification and characterization of miRNAs that regulate neutrophil recruitment
As a first step to understand microRNA mediated gene regulation in zebrafish neutrophils, we sequenced microRNAs in zebrafish neutrophils sorted from 3 day old embryos. Consistent with previous reports in human and mice, miR-223 and miR-142 were among the microRNAs highly expressed in zebrafish neutrophils (Fig. 1a, b and Dataset 1). As a control, we sequenced microRNAs in the immotile epical keratinocytes and indeed detected a distinct profile ( Fig.1c, d) . We next performed a functional genetic screen to identify a set of miRNAs overexpression of which moderates neutrophil migration ( Supplementary Fig. 1 ). Forty-one microRNAs with lower expression levels compared with the whole embryo or keratinocytes were selected. Individual miRNA candidates were cloned and transiently expressed in zebrafish neutrophils, together with a fluorescent reporter gene. The miRNAs whose overexpression resulted in an over 50% reduction in neutrophil recruitment to infection sites were selected (Dataset 2). We generated transgenic zebrafish lines stably expressing the eight miRNAs that passed the initial screen. To rule out potential artifacts associated with the transgene integration sites, more than two independent founders were obtained for each line. In seven out of the eight lines, reduced neutrophil recruitment to ear infection sites were detected, regardless of the choice of the founder (Fig. 1e ). Using a tailfin amputation inflammatory model, neutrophil recruitment was significantly inhibited in all eight lines ( Fig. 1f and Dataset 3), concluding that the microRNA overexpression screen faithfully represented microRNAs which could modulate neutrophil migration. A microRNA characterized in our previous work, miR-722, served as a positive control 20 . Among the eight newly identified miRNAs, miR-146 is a known suppressor of immune cell activation 21 , whereas the other 7 miRNAs have not been characterized for their roles in neutrophilic inflammation or migration. The overexpression of miR-199-3 resulted in the most robust inhibition in both models ( Fig. 1e -j) and therefore was selected for further characterization.
miR-199-3 overexpression inhibits neutrophil motility and chemotaxis.
To characterize the zebrafish lines Tg(lyzC: pu19 and Tg(lyzC:Dendra2vector) pu7 , hereby referred as miR-199 and vector lines, we first isolated their neutrophils and performed miRNA RT-qPCR to confirm the miR-199 overexpression in the miR-199 line ( fig.  2A ). The levels of two abundant neutrophil miRNAs, miR-223 and let-7e, were not affected, showing that the overexpression did not disrupt physiological microRNA levels. Total neutrophil numbers in embryos were comparable between the two lines, suggesting that the observed decreased neutrophil recruitment was not an artifact of reduced neutrophil numbers (Fig. 2b, c) . In addition to defective recruitment to inflammatory sites, the velocity of neutrophil spontaneous motility in the head mesenchyme was significantly decreased in the miR-199 line (Fig 2d, e and Video S1), whereas their directionality was not affected (Fig. 2f ). The sequences of the mature zebrafish and human miR-199-5p isoforms are identical ( Fig. 3c ).We therefore sought to determine whether MIR-199 inhibits human neutrophil migration. We used MIR-100, whose overexpression did not result in any phenotype in the initial screen, as a negative control. We expressed MIR-199a, MIR-100 or the vector alone under the control of a Tet Responsive Element in HL-60 cells, a myeloid leukemia cell line that can be differentiated into neutrophillike cells as our model 22 ( Supplementary Fig. 2a ). MIR-100 and MIR-199 were individually induced in the respective lines without affecting cell differentiation, cell death or the expression of two other miRNAs, MIR-223 and LET-7 ( Fig. 2g and Supplementary Fig. 2b-d ). The cells were then allowed to migrate towards N-Formylmethionyl-leucyl-phenylalanine (fMLP) in transwells. Only the cells overexpressing MIR-199, but not the vector control or cells overexpressing MIR-100, displayed significant defects in chemotaxis ( Fig. 2h ). Together, our results show that overexpression of MIR-199 inhibits neutrophil migration in both zebrafish and human cell models.
miR-199 suppresses the expression of cell cycle-related genes including cdk2
To understand the underlying molecular mechanism of how miR-199 regulates neutrophil migration, neutrophils from the miR-199 or vector lines were isolated and their transcripts subjected to RNAseq. Transcripts that were downregulated upon miR-199 overexpression 23 were subjected to further analysis ( Fig. 3a and Dataset 4). To our surprise, the top 10 pathways associated with the downregulated transcripts are related to cell cycle processes ( Fig. 3b and Dataset 5). This result was surprising because neutrophils are known to be terminally differentiated, non-proliferative, and have exited the cell cycle 24 . To validate the RNAseq results, we selected 5 genes, cdk2, cdk5, cdca8, kif14, and mcm5, which were significantly downregulated, and confirm their reduced transcript levels in the miR-199 line using RT-qPCR ( Fig. 3c ). The zebrafish orthologue of IKBKB, a known target of human MIR-199 25 and a critical component in the NF-κB pathway, was also downregulated, supporting the conservation of microRNA-target interactions in zebrafish. The level of cyclin dependent kinase 1 (cdk1) mRNA was not altered. The protein sequence of CDK2 is more than 90% identical between zebrafish and human, and both 3´ UTRs contain predicted miR-199-5p binding sites ( Fig. 3d ). To demonstrate direct targeting of cdk2 mRNAs by miR-199-5p, we performed dual-luciferase reporter assays. miR-199 significantly reduced the relative luciferase activity controlled by both the human and zebrafish cdk2 3´UTRs but did not show the repression of luciferase activity when the predicted binding sites were mutated ( Fig. 3e ). These results indicate that miR-199 suppresses classical cell cycle pathways in neutrophils and directly targets cdk2 in both zebrafish and humans.
Pharmacological inhibition of Cdk2 decreases neutrophil motility and chemotaxis
CDK2 is expressed and active in human neutrophils 26 . To test whether cdk2 regulates neutrophil migration, we used NU6140 27 , a CDK2 specific inhibitor. At a concentration of 100 µM, NU6140 did not affect zebrafish survival or neutrophil numbers ( Supplementary Fig. 3 ). As a control for cell cycle progression and DNA replication, we used a mixture of Aphidicolin and hydoxyurea (ApH), as previously reported 28, 29 in an attempt to uncouple the role of Cdk2 from DNA replication. Neutrophil recruitment to the infected ear ( Fig. 4a , b) or tailfin amputation sites ( Fig. 4c, d ) was significantly reduced by the Cdk2 inhibition, but not by DNA replication inhibition. Cdk2 inhibition did not affected total neutrophil numbers in the fish (Fig. 5e, f ). In addition, neutrophil motility, but not directionality, was significantly inhibited by the Cdk2 inhibitor ( Fig. 4g -I and Video S2), recapitulating the phenotypes resulted from miR-199 overexpression. To increase our confidence of the results obtained with pharmacological Cdk2 inhibition, two additional Cdk2 inhibitors 30 were used. A CDK2 selective inhibitor CTV313 and a pan-CDK inhibitor roscovitine also blocked neutrophil motility and recruitment in inflammation models ( Supplementary Fig. 4 and Video S2). We then tested whether the neutrophils under investigation had indeed exited the cell cycle. No cell division was observed during wounding or infection ( Supplementary Fig. 5a , b and Video S3), suggesting that neutrophil division is a rare event. Additionally, less than 3% of the neutrophils in adult kidney marrow were in the S or G2 phase ( Supplementary Fig. 5c-e ). Because cdk2 has not been previously implicated in regulating neutrophil migration, primary human neutrophils were isolated and treated with NU6140. Inhibition of CDK2 significantly reduced chemotaxis toward Interleukin-8 (IL-8), with a decreased velocity and chemotaxis index ( Fig. 4j -l and Video S4). In summary, we report a previously unknown role for cdk2 in regulating neutrophil chemotaxis in a way separable from its function in DNA replication.
Catalytic activity of Cdk2 is required for neutrophil motility
We further tested our hypothesis that the kinase activity of Cdk2 is essential for neutrophil motility. We cloned the zebrafish cdk2 gene and tagged it at the N-terminus with mCherry linked via a self-cleavable 2a peptide ( Fig. 5a ). Mutations at D145, a residue that chelates Mg +2 and facilitates ATP binding to the catalytic cleft 31 , resulted in a catalytic-dead and dominantnegative form of Cdk2. We constructed zebrafish lines overexpressing cdk2 (D145N) in neutrophils, Tg(lyzC:mcherry-2a-cdk2-d145n) pu19 , together with a control line Tg(lyzC:mcherry-2a-cdk2) pu20 , hereby referred to as cdk2 D145N or the WT line. We observed a significant reduction of neutrophil motility ( Fig. 5b-d and Video S5) and recruitment to the tail amputation site ( Fig. 5e , f) in the D145N line. To characterize neutrophil chemotaxis to a single chemoattractant, we bathed embryos from the two lines in Leukotriene B4 (LTB4) and quantified neutrophil emigration from the caudal hematopoietic tissue (CHT) to the caudal fin. The percentage of neutrophils migrating outside the CHT and the distance neutrophils traveled in the caudal fin were significantly reduced in the D145N line ( Fig. 5g , h, Supplementary Fig. 6a , b and Video S6). In addition, neutrophil motility in the CHT was reduced ( Supplementary Fig. 6c , d and Video S7). To visualize neutrophil cell polarity, the cdk2 D145N or the WT lines were crossed with Tg(mpx:GFP-UtrCH) which labels stable actin in the trailing edge of migrating neutrophils 32, 33 . In Cdk2 D145N expressing neutrophils, stable actin is enriched in transient cell protrusions that quickly retract in multiple directions, displaying disrupted cell polarity and actin dynamics ( Fig.5i and Video S8). Together, our results indicate that the catalytic activity of Cdk2 is required for neutrophil polarization and chemotaxis.
miR-199 overexpression or Cdk2 inhibition ameliorates systemic inflammation
With the findings that miR-199 overexpression or cdk2 abrogation hinders neutrophil chemotaxis, we sought to determine whether these manipulations could alleviate acute systemic inflammation caused by P. aeruginosa infection 34, 35 . We thus administered a lethal dose of P. aeruginosa directly into the circulation in zebrafish embryos. Survival of the embryos was significantly improved in the miR-199 line and the cdk2 D145N line compared with their respective control lines (Fig. 6a, b ). Consistently, NU6140 treatment improved the infection outcome whereas DNA replication inhibitors were detrimental to the infected host ( Fig. 6c ). Roscovitine, a pan CDK inhibitor 36 currently in phase-II trial for cancer treatment, also displayed a protective effect at 15 µM but was detrimental at 30 µM, possibly resulted from the inhibitory effect on cell proliferation and tissue repair as previously reported in cell culture and ex vivo bone marrow isolations 37, 38 (Fig. 6d ). To assess further the protective effect of dampening neutrophilic inflammation during systemic inflammation, we utilized a sterile inflammation model of endotoxemia 39 . Neutrophil-specific miR-199 overexpression or roscovitine treatment reduced host mortality ( Fig. 6e, f) , indicating a host protective effect of miR-199 overexpression and Cdk2 inhibition during acute systemic inflammation and infection, without generating broad immune suppression.
Discussion
microRNAs play a pivotal role in diseases driven by neutrophilic inflammation 40, 41, 42 where both protective and detrimental effects have been noted. Currently, there is no systemic screen to identify miRNAs that can suppress neutrophil migration, possibly because neutrophils are terminally differentiated and not genetically tractable in cell culture. A microRNA overexpression screen was performed in B cells 13 , but not in other immune cells. In the present study, we performed an in vivo functional screen in the zebrafish and identified miR-199 as a critical evolutionarily conserved regulator of neutrophil migration and chemotaxis. miR-199 hindered neutrophil motility by downregulating genes in the canonical cell cycle pathways, and by directly targeting Cdk2. We further showed that the catalytic activity of Cdk2 was critical for neutrophil migration and chemotaxis, whereas an active cell cycle and DNA replication were not essential ( Supplementary Fig. 6e ).
Whereas no previous studies have investigated the role of miR-199 in neutrophils, its role in suppressing inflammation and cell migration has been reported in cancer cells. In ovarian cancer cells, miR-199 inhibits canonical NF-κB signaling by targeting ikbkb, thus preventing the production of pro-inflammatory cytokines 25 . In our current work, the miR-199-ikbkb axis was also validated in neutrophils, further supporting the evolutionary conservation of miRNA-target interaction in vertebrates. Suppression of ikbkb may also contribute to the survival of zebrafish during systemic inflammatory challenge due to its central role in inflammation. From the perspective of cell migration, miR-199 hinders cancer cell migration and invasion by downregulating β 1 integrin levels 43 , decreasing CD44 and interaction with Ezrin 44 , or by directly targeting α 3 integrin 45 in various cancer cells. Low levels of miR-199 correlate with poor prognosis, increased cell proliferation and metastasis. Subsequent introduction of miR-199 alleviated invasiveness in vitro through targeting the Wnt or HIF-1α/VEGF pathways 46, 47 . Here we provide evidence that miR-199 is a suppressor of cell migration in leukocytes, expanding its role to inflammation. Our observation is in line with a recent report that miR-199a-5p is increased in the plasma in patients with neutrophilic asthma 48 and inflammatory bowel disease 49 , suggesting that miR-199 may play physiological functions in inflammation. In addition, miR-199b suppress myeloid differentiation 50 , which can also contribute to its role in suppressing the innate immunity.
The most surprising finding of our study is that miR-199 predominantly regulates the cell cycledependent kinase CDK2 in terminally differentiated neutrophils that have exited the cell cycle. The function of CDK2 has not previously been investigated in the context of inflammation. CDK2 is a cell cycle-dependent kinase whose cofactors, cyclin E and A, are expressed during mitosis, activating its kinase activity and cell cycle progression 51 . CDK2 is a facilitator of the cell cycle during G1/S phase (with cyclin E) and S/G2 phase (with cyclin A) 52 , and deletion of CDK2 prolongs but does not inhibit cell cycle progression 53 . CDK2 is required for meiosis during mammalian gametogenesis. In addition, CDK2 phosphorylates transcriptional factors to drive cell cycle progression and cell differentiation, and to alter cell metabolism and DNA double-strand break repair 54 .
We provided evidence that the kinase activity of CDK2 is required for neutrophil migration. The limitation of our work is that the direct phosphorylated substrate of CDK2 in neutrophils are not identified, which presents a significant challenge. CDK2 is a serine/threonine protein kinase, which uses the KLAD*FGLA kinase consensus domain to phosphorylate the "Ser/Thr-Pro-X-basicAA" motif of target proteins, although noncanonical target motifs are prevalent 55 . Over a hundred proteins are likely phosphorylated by CDK2-cyclinA in HEK cells 56 and the CDK2-cyclinE substrates are not all characterized. Thus extensive work will be required to characterize how CDK2 contributes to the signaling network required for neutrophil chemotaxis and identify the proteins that are phosphorylated by CDK2 in neutrophils. CDK2 is present in the neutrophil cytosol and its expression is upregulated upon LPS stimulation 57 , supporting the possibility that CDK2 ties in the signaling pathways downstream of the immune receptors in neutrophils. As a step closer to the potential mechanism, we have visualized the actin dynamics and the cell polarity in neutrophils with the dominant-negative Cdk2 overexpression. Indeed, stable actin is enriched in the transient protrusions that quickly retract, a phenotype resembling the over expression of a dominant negative Rac2 construct and after PI3K inhibition 33, 58 . It is likely that Cdk2 regulates the Rac2-PI3K axis, which is essential in cell motility.
Acute neutrophilic over-inflammation is a pressing concern in many diseases pathologies 1 and methods of hindering neutrophil migration and inflammation while preserving immune integrity and highly desired. Our study presents an acute method to dampen neutrophil recruitment by inhibiting Cdk2, which reduced the lethality caused by acute systemic inflammation. The pan-CDK inhibitor roscovitine competes with ATP for the occupation of the kinase active site 59 and is currently in multiple phase II clinical trials to inhibit cystic fibrosis and multiple types of tumors (clinicaltrials.gov). Previous studies in mice have shown that treatment of roscovitine at 10-100 mg/kg for 3-7 days after inflammation induction resulted in decreased neutrophil infiltration into the inflamed tissue and better clinical outcome 60 . This reduced neutrophil recruitment was attributed to CDK9 inhibition and neutrophil apoptosis 61 and a direct link to CDK2 was not shown. Cdk2 knockout mice show normal myeloid cell numbers during resting and stressed conditions 62 and no developmental defects besides having a smaller body size and sterility 63 . Thus CDK2 inhibition is not expected to cause adverse side effect and thus present an attractive strategy for short-term and long-term control of inflammation. Inhibition of CDK2 has been extensive studied in cancers to inhibit cancer cell proliferation 64 but to our knowledge the effect of cdk2 inhibition in neutrophil function or inflammation has not been characterized. Our results here provide a mechanistic understanding of the neutrophil inhibitory effect of roscovitine and suggest a future direction of utilizing Cdk2 specific inhibitors in managing inflammation, which may be better tolerated than a pan-Cdk inhibitor such as roscovitine.
In summary, our present study demonstrates previously unappreciated roles of miR-199 and CDK2 in regulating neutrophil migration and points to new directions in managing neutrophilic inflammation.
Materials and Methods:
microRNA seq Neutrophil and apical epithelial cells were sorted from transgenic zebrafish lines Tg(lyzC:GFP) and Tg(Krt4:GFP) at 3 day post fertilization (dpf) using fluorescence-activated cell sorting. Total RNA was exacted using Ambion mirVana kit (without enrichment for small RNA). Library was prepared using TruSeq Small RNA Preparation (illumina). After library construction, DNA of 145-160 bp were excited from Invitrogen 6% Novex TBE Gel and sequenced using Illumina HiSeq2000 with paired-end reads of 50 bp with a total of 2-3M/sample. MicroRNA sequence is performed at University of Wisconsin Collaborative Genomics Core. For analysis, sequencing reads were map to the zebrafish genome (GRCz11) using RNA-seq aligner from STAR (v2.5) 65 with the parameter: "--alignEndsType EndToEnd --outFilterMismatchNmax 1 --outFilterMultimapScoreRange 0 --outFilterMultimapNmax 10 --outSAMunmapped Within --outFilterScoreMinOverLread 0 --outFilterMatchNminOverLread 0 --outFilterMatchNmin 16 --alignSJDBoverhangMin 1000". FeatureCounts (from subread v1.5.1) 66 was used to evaluate expression levels of zebrafish mature microRNAs based on uniquely mapped reads with the parameters: "-s 1 -Q 10". Before TMM normalization and DE analysis by edgeR (v3.20.8) 67 , microRNAs whose CPM was less than 10 were removed from all samples. Differentially expressed microRNAs were selected if their FDR-adjusted p-values were less than 0.05.
RNA seq
Kidney marrow was dissected from 2 adults from Tg(lyzC:Dendra2-miR-199-3) pu19 or Tg(lyzC:Dendra2-vector )pu7 and neutrophils were sorted using fluorescence-activated cell sorting. Total RNA was extracted using RNeasy Plus Mini Kit (Qiagen #74104). RNAseq was performed at The Center for Medical Genomics at Indiana University School of Medicine. Samples were polyA enriched and sequenced with Illumina HiSeq 4000 ultra low with reads range from 37M to 44M. The RNA-seq aligner from the STAR (v2.5) 65 were employed to map RNA-seq reads to the reference genome, zebrafish (GRCz11), with the following parameter: "--outSAMmapqUnique 60". Uniquely mapped sequencing reads were assigned to genes using featureCounts (from subread v1.5.1) 68 with the following parameters: "-p -Q 10". The genes were filtered for further analysis if their count per million (CPM) of reads was less than 0.5 in more than 3 samples. The method of trimmed mean of M values (TMM) was adopted for gene expression normalization cross all samples, followed by differential expression analysis between different conditions using edgeR (v3.20.8). Differentially expressed gene was determined for the comparison if its false discovery rate (FDR) adjusted p-value was less than 0.05 and the amplitude of fold change (FC) was larger than linear 2-fold. The functional analysis was performed on DEGs of our interest with a cutoff of FDR < 0.05 to identify significantly overrepresented Gene Ontology (GO) and/or KEGG pathways by using the DAVID 69 .
Quantitative RT-PCR:
Total RNA was purified using MiRVANA miRNA purification kit (ThermoFisher). MicroRNAs were reverse transcribed with Universal cDNA Synthesis Kit II (Exiqon). MicroRNA RT-qPCR was performed with ExiLENT SYBR® Green master mix (Exiqon) using LightCycler ® 96 Real-Time PCR System (Roche Life Science). Messenger RNAs were reverse transcribed with Transcriptor First Strand cDNA Synthesis Kit (Roche). RT-qPCR were performed with FastStart Essential DNA Green Master (Roche). The specificity of the primers were verified with a single peak in the melt-curve. The relative fold change with correction of the primer efficiencies was 
Generation of transgenic zebrafish lines
The zebrafish experiment was conducted in accordance with internationally accepted standards. The Animal Care and Use Protocol was approved by The Purdue Animal Care and Use Committee (PACUC), adhering to the Guidelines for Use of Zebrafish in the NIH Intramural Research Program (protocol number: 1401001018). 300-600bp genomic DNA fragments flanking the respective miRNA were PCR amplified from zebrafish genomic DNA using specific primers and inserted into the BbsI site in the vector backbone as described 20 . Zebrafish cdk2 gene was cloned from zebrafish mRNA using SuperScript III RT-kit (Invitrogen #18080044) and amplified with the following primers. zCdk2+: 5′-GAAAACCCCGGTCCTATGGAGTCTTTTCAGAAAGTGGAG-3′; zCdk2-: 5′-CATGGCTGATTATGATTATAGGCGTAAAGGAGGCACTGG-3′ and inserted into a Tol2mcherry-2A backbone. Point mutation was generated using infusion (Takara #638920) site directed mutagenesis with zCdk2 DN+: 5′-ACTGGCTAACTTTGGTTTGGCCAGAGCGTTC -3′; zCdk2 DN -: 5′-CCAAAGTTAGCCAGTTTGATCTCGCCCTG -3′. The plasmids were injected into zebrafish embryo at 1-cell stage and the stable line were generated as previously described 33 . At least two founders (F0) for each line were obtained. Experiments were performed using F2 larvae produced by F1 fish derived from multiple founder to minimize the artifacts associated with random insertion sites.
Dual luciferase reporter assay:
Both zebrafish and human CDK2 3′UTR were amplified from zebrafish genomic DNA with SuperScript III RT-kit (Invitrogen #18080044) and cloned into psiCHECK2 (Promega) at XhoI and NotI cloning sites with the following primers: zCDK2+: 5′-TAGGCGATCGCTCGAGAACGAGATCAACTTTGGCAAG-3′; zCdk2-: 5′-TTGCGGCCAGCGGCCGCTGTAACAACATAAACCAAATGTT-3′, hCDK2+: 5′-TAGGCGATCGCTCGAGAGCCTTCTTGAAGCCCCCA-3′; hCdk2-: 5′-TTGCGGCCAGCGGCCGCTATAAAACTAGGCACATTTTTTTAA-3′. Mutated 3′UTR constructs were generated using Infusion HD cloning kit (Clontech) with the following primers: zCdk2 mut+: 5′-CCTGTGTGACCCAAAAAAACAGCTGTGCTAATAGT-3′; zCdk2 mut-: 5′-TTTGGGTCACACAGGTTGCAATGGATAATCTTCA-3′, hCdk2 mut+: 5′-AAAACGTGACCGAGGAGTCTATTTTAAAGAATTCGG. DNA encoding miR-199 or vector were amplified from the construct used for expression in zebrafish and inserted into pcDNA3.1 at the HindIII/XbaI cloning sites using the following primers: pcDNA-199+: 5′-GTTTAAACTTAAGCTTGCCACCATGGATGAGGAAATCGC-3′; pcDNA-199-: 5′-AAACGGGCCCTCTAGAGACCGGTACCCCCGGGCTGC-3′.
Live imaging:
Larvae at 3 dpf were settled on a glass-bottom dish and imaging was performed at 28.5 ºC. Timelapse fluorescence images in the head mesenchyme were acquired with a laser-scanning confocal microscope (LSM710, Zeiss) with a Plan-Apochromat 20×/0.8 M27 objective. Neutrophil motility at the caudal hematopoietic tissue was imaged using Zeiss EC Plan-NEOFLUAR 10X/0.3 objective. For neutrophil nucleus and cytosol reporter line imaging, a LD C-Apochromat 40x/1.1 W Korr M27 was used. The green and red channels were acquired sequentially with 0.1~0.3% power of the 488 nm laser and 0.5%~2% of 561 nm laser, respectively, with a 200 µm pinhole at a speed of 1.27 µs/pixel and averaged (line 2). The fluorescent stacks were flattened using the maximum intensity projection and overlaid with a single slice of the bright-field image. Neutrophil chemotaxis upon LTB4 treatment was captured with a Zeiss ZV16 dissection microscope at 2x magnification every 15sec for 30 minutes.
Inflammation assays in zebrafish:
Zebrafish wounding and infection were performed as described 20 . For LTB4 recruitment assays, 3 dpf zebrafish larvae were treated with 30 nM LTB4 for 15 minutes and fixed. Neutrophils were stained with Sudan Black and the number at the indicated regions were quantified.
Generation of stable HL-60 cell lines:
HEK-293 cells were cultured in DMEM supplemented with 10% FBS, 4.5 g/glucose and sodium bicarbonate. HL-60 cells were obtained from ATCC (CCL-240) and cultured using RPMI-1640 with HEPES supplemented with 10% FBS and sodium bicarbonate. The lentiviral backbone pLIX_403 was a gift from David Root (Addgene plasmid # 41395). The DNA sequence flanking MIR-199 was cloned from HL-60 cell genomic DNA and cloned into a backbone containing Dendra2. The miRNA and dendra2 reporter were then cloned into pLIX_403 vector using the NheI/AgeI sites with primer set: pLIX-mir+: 5' TGGAGAATTGGCTAGCGCCACCATGGATGAGGAAA TCGC-3', pLIX-mir-: 5'-CATACGGATAACCGGTTACCACACCTGGCTGGGC-3'. Stable HL-60 cell lines were generated as described. 70 Briefly, HEK-293 cells were transfected with pLIX_403, VSV-G and CMV8.2 using lipofectamine 3000 (ThermoFisher). The viral supernatant was harvested on day three and concentrated with Lenti-X concentrator (Clontech). HL-60 Cells were infected at 2000 g for 2 h at 32 ºC and maintained in medium supplemented with 1 µg/ml puromycin. Live cells that excluded trypan blue were counted using a hemocytometer.
Flow Cytometry:
Cells were stained with Alexa Fluor 647 conjugated CD11b (neutrophil differentiation marker, Biolegend, 301319, clone IV-M047, 2ul to 1X10 6 cells) or the isotype control antibody (Biolegend, 400130, clone MOPC-21, 2ul to 1X10 6 cells) and RUO AnnexinV (apoptosis marker, BD, 563973, 5ul to 1X10 6 cells). Cells were stained in staining buffer (1% BSA, 0.1% NaN3) and incubated on ice for 1 hour, washed three times with staining buffer and resuspended in suitable volumes. Cell cycle profiling was obtained using Vybrant™ DyeCycle™ Ruby Stain (Thermo #V10309) following the manufacture's protocol. Fluorescence intensity were collected using BD LSR Fortessa. Results were analyzed with Beckman Kaluza 2.1 software.
Inhibitor treatment for zebrafish larvae:
CDK2 inhibitors NU6140 (Enzo # ALX-270-441), CTV313 (Sigma #238803) and roscovitine (Selleckchem #S1153) were dissolved in DMSO to make a 100 mM stock, then further diluted in E3 to working concentrations (100 µM for recruitment and motility assays, and indicated concentration for survival assays). For inhibiting DNA replication, 150 μ M aphidicolin and 20 mM hydroxyurea (Sigma #A0781) in 1% DMSO was used as previously described 28, 71 . For neutrophil recruitment and random motility assays, larval were pretreated with the inhibitor for 1 h before experimental procedures. For survival assays, larval were pretreated and kept in the inhibitors from1 hour post infection.
Primary neutrophil isolation and chemotaxis assay:
Primary human neutrophils were isolated with Milteny MACSxpress Neutrophil Isolation Kit. Cells were stain for 10 min with Calcein AM and washed with PBS. 10 million cells/ml were incubated in RPMI+0.1% HSA containing 50 µM NU6104 or DMSO at 37ºC/5% CO 2 for 45 min. Microfluidic devices were fabricated as previously described 72 . Microfluidic chambers were coated with 10 μ g/ml fibrinogen for 1 h at 37 °C in PBS. 3 μ l of neutrophil suspension (4 × 10 6 cells/ml) was added to the device, and 5 μ M IL-8 was added to the source port. The gradient was allowed to set up and equilibrate in a 37 °C humidified chamber for 15 min before imaging. Time-lapse imaging was performed using a 10×, NA of 0.45, or 60×, NA of 1.4 objective and motorized stage (Ludl Electronic Products) on an inverted microscope (Eclipse TE300) using a charge-coupled device camera (CoolSNAP ES2) and captured into MetaVue imaging software v6.2. Images were taken every 30 s for 30-45 min with up to eight devices being imaged simultaneously. Tracking and velocity quantification were performed as described 7 .
Statistical Analysis:
Statistical analysis was carried out using PRISM 6 (GraphPad). Mann-Whitney test (comparing two groups), Kruskal-Wallis test (when comparing to single group), and Gehan-Breslow-Wilcoxon test (for survival curve comparison) were used in this study as indicated in the figure legends. Individual p values are indicated in the figure with no data points excluded from statistical analysis. One representative experiment of at least three independent repeats are shown. For qPCR, each gene was normalized to a reference gene and compared with Holm-Sidak test (individual comparison with paired value) where each p value and DF was adjusted for respective multiple comparisons. 
